Instructions for Authors



Journal of Dental Implant Research is the official peer-reviewed, quarterly publication of the Korean Academy of Implant Dentistry(KAID). The Journal publishes original research papers, clinical observations, review articles, viewpoints, commentaries, technical note, case reports, and letters to the editor in subjects relating to clinical practice and research into dental implantology.

1. Editorial Policy

 All submitted manuscripts should be original and should not be considered by other scientific journals for publication at the same time. Any part of the accepted manuscript should not be duplicated in any other scientific journal without permission of the Editorial Board. If duplicate publication related to the papers of this journal is detected, the authors will be announced in the journal and their institutes will be informed, and there also will be penalties for the authors. Review and procedures on all ethics related issues including ethical regulations and plagiarism/redundant publication/research misconducts follow Good Publication Practice Guidelines for Medical Journals (http://www.kamje.or.kr/publishing_ethics.html) made by Korean Association of Medical Journal Editors.

2. Copyright

Copyright of all published materials are owned by the Korean Academy of Implant Dentistry and authors must sign to agree with submission regulations on the application form for submission.

3. Language

A manuscript can be written in English. Abstract and references of all manuscript should be written in English.

4. Submission of Manuscript

Manuscript should be submitted in the file format of Microsoft Word Software. Manuscripts should be typed on A4 size, double-spaced, using font size of 10 with margins of 25 mm on each side and 30 mm for the upper and lower ends. The article should be organized in the order of Cover page, Abstract, Text, References tables, figure Legends, Figures. Each new section's title should begin on a new page. Number pages consecutively, beginning with the Cover page. Page numbers should be placed at the middle of the bottom of page.

5. Cover Page

1) Cover page should include the title, the names of authors, the affiliation of authors, the information of corresponding author, and running title. Conflict of interest, Acknowledgement (if necessary).  
2) Title should be concise and precise. Only the first letter of the first word of title should be capitalized. The names of the authors should be fully described.  
3) Names of authors are arranged according to contribution to the manuscript. Leading author (first author) is presented first, then other authors are written in detail. The names of authors are separated with commas and English names are shown as full name.   
(Ex) Chul-Soo Kim, Jong-il Lee  
4) One organization shall be indicated without number and if there are two or more organizations, those of the first and other authors shall be numbered in order in shoulder brackets and written in Korean and English at the bottom of the cover. The English-written organizations shall have only their first letters and proper nouns indicated in capital letters. If an author belongs to two or more organizations, they shall be indicated in shoulder numbers, which shall have commas placed between themselves:
(Ex) Chul-Soo Kim1,2, Jong-il Lee2
1Department of Oral and Maxillofacial Surgery, College of Dentistry, ○○ University, 2Department of Oral and
Maxillofacial Surgery
5) The information of corresponding authors
A corresponding author shall be indicated separately. Its name, organization and address shall be indicated in both Korean and English. Telephone and fax numbers and email address shall be placed below them.
6) Running title (less than 10 words) should be included in cover page.

6. Abstract

All manuscripts should be structured with four subsections: Purpose, Materials and Methods, Results, and Conclusions, length of abstract should be equal to or less than 300 words. The abstract for a case report or narrative review shall be written as only one paragraph, without being divided into the structures. A list of keywords, with a maximum of 6 items, should be included at the end of the abstract. If possible, whether the keywords are included in the Medical Subject Heading (MeSH) of the National Library of Medicine is checked.
(Ex) key words: Implant, Bone graft,….

7. Text

1) Introduction   
The purpose, the academic background and the principal of a manuscript are summarized and references are limited to directly related ones. It should not discuss a related topic extensively and cite one after another like collective or current review. Also, it should not contain results or conclusion, which will be reported.
2) Materials and Methods   
This part describes research methods. Patients, experimental animals or control group should be presented clearly and written in detail for other researchers to perform a same study by following the methods. In particular, methods of identifying a target disease and of controlling subjectivity of observers should be explained. Machinery or reagents shall have their names, manufacturers, cities and countries specified in brackets. or TM shall not be used. If they are repeated, drug or product names alone shall be specified.
(Ex) Only Xenogenic bone (Bio-Oss, Geistleich Pharmaceutical, Wolhusen, Switzerland) was used and Bio-Oss with
size of 1,000 ㎛ or less was used.
Well-known methods including ones for statistical analysis should present references, and relatively new methods or modified methods from existing ones should provide references, introduce them simply and explain reasons why authors used them and their advantages and disadvantages.   
P-value, used in statistics, shall be indicated in capital letter and italics.
(Ex) P<0.05
3) Results
Results are reported by following a logical order and use tables, figures or pictures used. Data given in tables and figures should not be repeated in a main text, and only critical points and progress are described.  
4) Discussion   
Among results important and new ones are emphasized and conclusions based on them are written. Contents shown in the introduction and the result parts should not be repeated. Application ranges of results, limitations for interpretation and applicability in future studies are written. In addition, this part compares and discusses other related studies and links the purpose and the conclusion of a study. At this time, conclusions not based on data or unsubstantiated opinions should be avoided. A possible new hypothesis from obtained data can be suggested and appropriate methods to confirm it also should be presented.  
5) Conclusions   
A question asked in the introduction, results from a research and a main idea of discussion are summarized clearly. At this time, results should not be repeated simply and authors' opinion obtained from a research should be included.

8. References Style

1) The accuracy of references is the responsibility of the authors. All references should be written in English. References should be numbers in the order they appear in the text and the number should be same with superior numbers in the main text.  
2) At the end of a sentence, a quotation number shall be placed before a period. Several references shall be listed with commas. Three or more references, listed in succession, shall be connected with each other, using "-".
(Ex) 1), 2, 3), 4-6), 5-7, 9, 10).  
3) The Authors' surnames are followed by abbreviations of their given names.
(Ex) Jones ER, Park JU
If the number of authors is six or less, all their names are presented and if it is seven or more, 'et al.' is used.
4) Reference form   
① Journals: Names of authors. Title of an article. Name of the journal (abbreviation registered in Index Medicus) year;volume:starting page-ending page (only changed number).     
(Ex) Jones ER, Smith IM, Doe JQ. Occlusion. J Prosthet Dent 1985;53:120-9.
② Books: Names of authors. title. edition. location of publication: publisher; year of publication.     
(Ex) Babush CA. Implants. 1st ed. Philadelphia: W.B. Saunders Co., 2001.   
③ When a chapter is quoted from a book: chapter author name. chapter title In: Editor name, ed(s). Book name. edition. City: publishing company; year: Beginning pageend page.     
(Ex) Skalak R. Aspects of biomechanical considerations. In: Branemark PI, Zarb GA, Albrektsson T (eds). Tissue-Integrated
Prostheses: Osseointegration in Clinical Dentistry. Chicago: Quintessence, 1985:117-28.

9. Tables

1) Tables are presented clearly on separate pages in English. Tables should be sent in Microsoft Word format(not as PowerPoint or Exel tables). The number and the title of a table or a graph are located on their upper left part. Its number presented in Arabic numerals follow the word. A period shall be placed behind an explanation.    
(Ex) Table 1. Patients distribution.  
2) Annotation
Parts marked with Arabic numerals are explained on the lower left part of a table or a graph. The note shall be placed in order of the original terms in brackets, their abbreviations and explanations:

10. Figures and Graphs

1) Not to be affected by reduction during the printing process, drawings or pictures should be large or clear enough on separate pages and they should be clean original ones. Their file resolution should be 300 dpi or more.  
2) Its number presented in Arabic numerals follows the word, "Fig" after a period and a space and is ended with a period in the order of its appearance in a main text.  
(Ex) A diagram shall be drawn (Fig. 1) and a photo shall be shaped.(Fig. 2)
3) Its title and explanation are written in English and the first character of the first word of a title is written in capitals.  
(Ex) Fig. 1. A diagram of figure. A. Circle. B. Rectangle.  
4) When several photos are placed in a figure, they shall be classified in capital letters A, B etc. and explained separately as follows.

11. Review of Manuscript

A submitted manuscript will be under peer review by two or more reviewers among reviewers designated by JDIR. The reviewers can demand revision or supplementation. The final decision of publication will be conducted by the editorial committee. If a manuscript is not suitable for publication after three times of revision, it is decided not to be published.
A referee may recommend "accept", " minor revision", "major revision," or "reject". If there is a marked discrepancy in the decisions between two referees or between the opinions of the author and referee(s), the Editor may send the manuscript to another referee for additional comments and a recommended decision. Three repeated decisions of "major revision" are regarded as a "rejection." The reviewed manuscripts are returned back to the corresponding author with comments and recommended revisions. Names and decisions of the referees are masked. A final editor's decision on acceptance or rejection for publication is forwarded to the corresponding author from the Editorial Office. The usual reasons for rejection are topics that are too specific and target audience that is too limited, insufficient originality, serious scientific flaws, poor quality of illustrations, or absence of a message that might be important to readers. Rarity of a disease condition is itself not an acceptable justification for a case report.

Revisions are usually requested to take account of criticisms and comments made by referees. The revised manuscript should be resubmitted via the web system. Failure to resubmit the revised manuscript within 2 months without any notice from the corresponding author is regarded as a withdrawal. The corresponding author must indicate clearly what alterations have been made in response to the referee's comments point by point. Acceptable reasons should be given for noncompliance with any recommendation of the referees.

12. Publication of JDIR

JDIR is principally published Four times for a year (at the last day of March, June, September, and December).

13. Research Ethics

All of the manuscripts should be prepared based on strict observation of research and publication ethics guidelines recommended by the Council of Science Editors (http://www.councilscienceeditors.org/), International Committee of Medical Journal Editors (ICMJE, http://www.icmje.org/), World Association of Medical Editors (WAME, http://www.wame.org/), and the Korean Association of Medical Journal Editors (KAMJE, http://www.kamje.or.kr/intro.php?body=eng_index). All studies involving human subjects or human data must be reviewed and approved by a responsible Institutional Review Board (IRB). Please refer to the principles embodied in the Declaration of Helsinki ( https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/) for all investigations involving human materials. Animal experiments also should be reviewed by an appropriate committee (IACUC) for the care and use of animals. Also studies with pathogens requiring a high degree of biosafety should pass review of a relevant committee (IBC). The approval should be described in the Methods section. For studies of humans including case reports, state whether informed consents were obtained from the study participants. The editor of JDIR may request submission of copies of informed consents from human subjects in clinical studies or IRB approval documents. The JDIR will follow the guidelines by the Committee on Publication Ethics (COPE, http://publicationethics.org/) for settlement of any misconduct.

Ensure correct use of the terms sex (when reporting biological factors) and gender (identity, psychosocial or Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals 16 www.icmje.org cultural factors), and, unless inappropriate, report the sex and/or gender of study participants, the sex of animals or cells, and describe the methods used to determine sex and gender. If the study was done involving an exclusive population, for example in only one sex, authors should justify why, except in obvious cases (e.g., prostate cancer). Authors should define how they determined race or ethnicity and justify their relevance. Authors should use neutral, precise, and respectful language to describe study participants and avoid the use of terminology that might stigmatize participant

14. Conflict of Interest

The corresponding author of an article is asked to inform the Editor of the authors' potential conflicts of interest possibly influencing the research or interpretation of data. A potential conflict of interest should be disclosed in the cover letter even when the authors are confident that their judgments have not been influenced in preparing the manuscript. Such conflicts may include financial support or private connections to pharmaceutical companies, political pressure from interest groups, or academic problems. Disclosure form shall be same with ICMJE Uniform Disclosure Form for Potential Conflicts of Interest http://www.icmje.org/coi_disclosure.pdf). The Editor will decide whether the information on the conflict should be included in the published paper. In particular, all sources of funding for a study should be explicitly stated. The JDIR asks referees to let its Editor know of any conflict of interest before reviewing a particular manuscript.

15. Authorship

JDIR accepts authorship criteria recommended by the International Committee of Medical Journal Editors (ICMJE).



e-submission

Current Issue

30 September 2021 Volume 40,
Number 3, pp. 59~111

Indexed/Covered by

  • renew
  • banner_koreatoothbank